Canna~Fangled Abstracts Therapeutic potentials of cannabidiol: Focus on the Nrf2 signaling pathway Review Biomed Pharmacother. 2023 Oct 28:168:115805. doi: 10.1016/j.biopha.2023.115805. Online ahead of print. Marjan Talebi 1, Mohammad Mehdi…Freedom WaresOctober 28, 2024
Canna~Fangled Abstracts The Potential Paradoxical Neurocognitive Effects of Cannabis Use in Patients with Psychotic Disorders: A Critical Meta-Review of Meta-Analytical Evidence Cannabis Cannabinoid Res. 2022 Jun 3. doi: 10.1089/can.2021.0163. Online ahead of print. Laura Dellazizzo 1 2, Stéphane Potvin 1 2, Sabrina…Freedom WaresJune 3, 2022
Canna~Fangled Abstracts Cannabidiol for at risk for psychosis youth: A randomized controlled trial Early Interv Psychiatry. 2021 Jun 30. doi: 10.1111/eip.13182. Online ahead of print. G Paul Amminger 1 2, Ashleigh…Freedom WaresJune 30, 2021
Canna~Fangled Abstracts In Vivo Availability of Cannabinoid 1 Receptor Levels in Patients With First-Episode Psychosis. JAMA Psychiatry. 2019 Jul 3. doi: 10.1001/jamapsychiatry.2019.1427. Borgan F1,2, Laurikainen H3,4, Veronese M5, Marques TR1,2,…Freedom WaresJuly 3, 2019
Canna~Fangled Abstracts An Update on Safety and Side Effects of Cannabidiol: A Review of Clinical Data and Relevant Animal Studies. Cannabis Cannabinoid Res. 2017 Jun 1;2(1):139-154. doi: 10.1089/can.2016.0034. eCollection 2017. Iffland K1, Grotenhermen F1. Author…Freedom WaresJune 1, 2017
Canna~Fangled Abstracts Antipsychotic medication in schizophrenia: a review. 2015 May 8. pii: ldv017. Lally J1, MacCabe JH2. Author information Abstract INTRODUCTION: Antipsychotic medications are…Freedom WaresMay 8, 2015